Susquehanna International Group
STOK icon

Susquehanna International Group’s Stoke Therapeutics STOK Stock Holding History

Susquehanna International Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$713K Sell
21,900
-23,800
-52% -$781K ﹤0.01% 8772
2025
Q4 		$1.45M Buy
+45,700
New +$1.37M ﹤0.01% 6333
2024
Q2 		– Sell
-10,100
Closed -$136K – 13195
2024
Q1 		$136K Buy
+10,100
New +$61.2K ﹤0.01% 10981
2021
Q3 		– Sell
-37,300
Closed -$1.26M – 13532
2021
Q2 		$1.26M Buy
37,300
+19,900
+114% +$703K ﹤0.01% 7120
2021
Q1 		$676K Buy
17,400
+3,400
+24% +$194K ﹤0.01% 8759
2020
Q4 		$867K Buy
14,000
+1,700
+14% +$77.9K ﹤0.01% 7048
2020
Q3 		$412K Sell
12,300
-2,000
-14% -$57.1K ﹤0.01% 8080
2020
Q2 		$341K Buy
+14,300
New +$339K ﹤0.01% 8130

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Susquehanna International Group's STOK Position: Q1 2026 in Review

Susquehanna International Group increased its Stoke Therapeutics (STOK) stake by 24% in Q1 2026, buying an estimated $370K and bringing the position to 57,291 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #6333.

Susquehanna International Group first reported a position in STOK in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.07M in Q4 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Susquehanna International Group held 57,291 shares of Stoke Therapeutics worth $1.87M as of Q1 2026.
  • Susquehanna International Group bought 11,269 Stoke Therapeutics shares in Q1 2026, an estimated $370K.
  • Stoke Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6333 holding.
  • Susquehanna International Group first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Stoke Therapeutics position peaked at $2.07M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.